Table 2.
External validation of PRS models in European populations using data from UK Biobank and CIMBA.
Model (data set) | SNPs | UK Biobank | CIMBA BRCA1 carriersa | CIMBA BRCA2 carriersa | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
AUC | OR | 95% CI | AUC | HR | 95% CI | AUC | HR | 95% CI | |||
(a) PRS models based on OCAC data | |||||||||||
Lasso (OCAC) | 1403 | 0.587 | 1.37 | 1.27–1.48 | 0.573 | 1.27 | 1.21–1.34 | 0.627 | 1.48 | 1.33–1.63 | |
Elastic net (OCAC) | 10,797 | 0.588 | 1.36 | 1.26–1.47 | 0.583 | 1.32 | 1.26–1.39 | 0.617 | 1.47 | 1.33–1.63 | |
Stepwise (OCAC) | 22 | 0.588 | 1.35 | 1.26–1.46 | 0.563 | 1.21 | 1.16–1.26 | 0.605 | 1.39 | 1.26–1.54 | |
Select and shrink (OCAC) | 27,240 | 0.588 | 1.38 | 1.28–1.48 | 0.592 | 1.36 | 1.29–1.43 | 0.624 | 1.49 | 1.35–1.64 | |
(b) PRS models based on meta-analysis of OCAC and CIMBA data | |||||||||||
Stepwise (OCAC-CIMBA)b | 36 | 0.595 | 1.39 | 1.29–1.50 | NA | NA | NA | NA | NA | NA | |
Select and shrink (OCAC-CIMBA) | 18,007 | 0.596 | 1.42 | 1.32–1.54 | NA | NA | NA | NA | NA | NA |
AUC area under the receiver operating characteristic curve, OR odds ratio, HR hazards ratio.
aEstimates are from unadjusted models.
bResults in CIMBA are overfitted as the CIMBA data was used for model development.